Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$1.43M Buy
4,723
+2,257
+92% +$681K 0.07% 92
2022
Q1
$822K Buy
+2,466
New +$770K 0.03% 117
2021
Q4
Sell
-302
Closed -$90.4K 1069
2021
Q3
$90.4K Buy
302
+43
+17% +$13.1K ﹤0.01% 439
2021
Q2
$71.4K Buy
259
+79
+44% +$20.1K ﹤0.01% 515
2021
Q1
$44.6K Buy
180
+40
+29% +$10.2K ﹤0.01% 577
2020
Q4
$36.3K Hold
140
﹤0.01% 583
2020
Q3
$30K Hold
140
﹤0.01% 564
2020
Q2
$27.3K Hold
140
﹤0.01% 565
2020
Q1
$18K Hold
140
﹤0.01% 579
2019
Q4
$19.5K Buy
+140
New +$19.2K ﹤0.01% 658

Other funds holding SNPS

RBC Europe's SNPS Position: Q2 2022 in Review

RBC Europe increased its Synopsys (SNPS) stake by 92% in Q2 2022, buying an estimated $681K and bringing the position to 4,723 shares worth $1.43M. The position accounts for 0.07% of the portfolio, ranked #92.

RBC Europe first reported a position in SNPS in Q4 2019 and has held it in 10 quarters since. 836 funds tracked by Wall St. Rank hold SNPS as of Q2 2022.

  • RBC Europe held 4,723 shares of Synopsys worth $1.43M as of Q2 2022.
  • RBC Europe bought 2,257 Synopsys shares in Q2 2022, an estimated $681K.
  • Synopsys made up 0.07% of RBC Europe's portfolio in Q2 2022, its #92 holding.
  • RBC Europe first reported a position in Synopsys in Q4 2019 and has held it in 10 quarters since.
  • 836 funds tracked by Wall St. Rank held Synopsys as of Q2 2022.

Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.